The predictors of the efficacy of pharmacological cardioversion with class III antiarrhythmic drug - nibentan in patients with persistent atrial fibrillation

被引：0
|
作者：
Bregvadze, I. [1 ]
Maykov, E. [2 ]
Sokolov, S. [2 ]
Golitsyn, S. [2 ]
Rozenshtraukh, L. [2 ]
Chazov, E. [2 ]
Pagava, Z. [1 ]
机构：
[1] Ctr Vasc & Heart Dis, Cardiol, Tbilisi, Georgia
[2] Cardiol Res & Prod Ctr, Clin Electrophysiol, Moscow, Russia
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6383
引用
收藏
页码：1374 / 1374
页数：1
相关论文
共 50 条
  • [31] Atrial function after cardioversion in patients with persistent atrial fibrillation
    Noda, K.
    Sunamura, S.
    Onodera, K.
    Tanita, A.
    Ogata, T.
    Takii, T.
    Namiuchi, S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [32] Novel antiarrhythmic class III drug nibentan: From experimental studies to clinical practice
    Rosenshtraukh, LV
    Ruda, MY
    Golitsin, SP
    Maykov, EB
    KARDIOLOGIYA, 2003, 43 (06) : 66 - 68
  • [33] Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat
    Blaauw, Y.
    Schotten, U.
    van Hunnik, A.
    Neuberger, H. R.
    Allessie, M. A.
    CARDIOVASCULAR RESEARCH, 2007, 75 (01) : 89 - 98
  • [34] Atorvastatin Given prior to Electrical Cardioversion Does Not Affect the Recurrence of Atrial Fibrillation in Patients with Persistent Atrial Fibrillation Who Are on Antiarrhythmic Therapy
    Demir, Kenan
    Can, Ilknur
    Koc, Fatih
    Vatankulu, Mehmet Akif
    Ayhan, Selim
    Akilli, Hakan
    Aribas, Alpay
    Alihanoglu, Yusuf
    Altunkeser, Bulent Behlul
    MEDICAL PRINCIPLES AND PRACTICE, 2011, 20 (05) : 464 - 469
  • [35] Sex differences in pharmacological cardioversion in patients with atrial fibrillation
    Liu, Yang
    Lip, Gregory Y. H.
    KARDIOLOGIA POLSKA, 2023, 81 (11) : 1065 - 1066
  • [36] Clinical Efficacy of Bepridil for Class I Antiarrhythmic Drug-Induced Atrial Flutter in Patients with Paroxysmal Atrial Fibrillation
    Hayashi, Hidemori
    Sumiyoshi, Masataka
    Suwa, Satoru
    Sakurai, Hidehiko
    Kawano, Yasunobu
    Sekita, Gaku
    Tokano, Takashi
    Nakazato, Yuji
    Daida, Hiroyuki
    JOURNAL OF ARRHYTHMIA, 2008, 24 (02) : 71 - 75
  • [37] RESTORATION OF SINUS RHYTHM IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION AND OBESITY: NEW POSSIBILITIES OF PHARMACOLOGICAL CARDIOVERSION
    Vlodzyanovskiy, V. V.
    Malkina, T. A.
    Sokolov, S. F.
    Saidova, M. A.
    Golitsyn, S. P.
    Rozenshtraukh, L., V
    Chazov, E., I
    KARDIOLOGIYA, 2017, 57 (10) : 80 - 86
  • [38] Efficacy and Safety of Bepridil for Patients with Persistent Atrial Fibrillation after Failed Electrical Cardioversion
    Egami, Yasuyuki
    Nishino, Masami
    Taniike, Masayuki
    Makino, Nobuhiko
    Kato, Hiroyasu
    Shutta, Ryu
    Tanouchi, Jun
    Yamada, Yoshio
    JOURNAL OF ARRHYTHMIA, 2011, 27 (02) : 131 - 136
  • [39] Does antiarrhythmic drugs premedication improve electrical cardioversion success in persistent atrial fibrillation?
    Toso, Elisabetta
    Iannaccone, Mario
    Caponi, Domenico
    Rotondi, Francesco
    Santoro, Antonio
    Gallo, Cristina
    Scaglione, Marco
    Gaita, Fiorenzo
    JOURNAL OF ELECTROCARDIOLOGY, 2017, 50 (03) : 294 - 300
  • [40] Pharmacological treatment of atrial fibrillation: Mechanisms of action and efficacy of class III drugs
    Lombardi, Federico
    Terranova, Paolo
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (14) : 1635 - 1653
12345